Recent Finacing
Recent Raise
Sentien Biotechnologies develops a clinical-stage therapy embedding mesenchymal stromal cells inside an extracorporeal blood-filtration device to deliver MSC-secreted factors for treating acute kidney injury and systemic inflammation.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors